Blog
Remedium Bio announces the publication of preclinical data demonstrating the performance of its adjustable dose gene therapy platform – Prometheus™
Prometheus™ was specifically designed as a subcutaneously injected gene delivery system, utilizing the same route of administration as most current therapeutic biologics. Remedium is applying the Prometheus™ platform technology to the development of its lead candidate RMD1202, a single injection disease-modifying…
Read more: Remedium Bio anno...NICE recommends targeted treatment for neuroendocrine cancer in the liver
People with neuroendocrine tumours (NETs) in the liver could benefit from a therapy that targets tumours with radiation while limiting exposure to healthy surrounding tissue, according to new guidance from the National Institute for Health and Care Excellence (NICE). NETs are cancers…
Read more: NICE recommends t...Launch of NIHR HealthTech Research Centre in Brain Health
The Centre is hosted by the South London and Maudsley (SLaM) NHS Foundation Trust, and led by Prof Dag Aarsland, Director of the Centre for Healthy Brain Ageing at Institute of Psychiatry, Psychology and Neuroscience and lead consultant for the…
Read more: Launch of NIHR He...NHS to try out Alzheimer's disease blood tests
A study to assess whether blood tests could help diagnose people with very early Alzheimer's disease, is being launched by the NHS. Read the full article here.
Read more: NHS to try out Al...NHS Wales to implement hosted lab solution, InterSystems TrakCare Lab Enterprise
InterSystems, an innovative data technology provider dedicated to helping customers solve the most critical data and information challenges, has announced that Digital Health and Care Wales (DHCW) will be implementing InterSystems TrakCare Lab Enterprise (TCLE) for use across the country. …
Read more: NHS Wales to impl...Luscii launches remote monitoring pilot with SBRI and Welsh Ambulance Services University NHS Trust
Luscii is delighted to announce they’re in a phase 2 contract with The Small Business Research Initiative (SBRI), as part of an innovative trial with the Welsh Ambulance Service University NHS Trust (WAST). The pilot is part of an initiative…
Read more: Luscii launches r...NAVIGATING THE DATA FRONTIER - REVOLUTIONISING HEALTH AND CARE THROUGH DATA
PRSB & Convenzis Group are bringing to you Navigating the Data Frontier: Revolutionising Health and Care Through Data. Join them for an event full of CDP-accredited sessions & insights around #DigitalTransformation, data and standards. Register here.
Read more: NAVIGATING THE DA...Explore how knowledge tasks enhance medical device UX!
In Bold Insight latest blog, they share insights from their presentation HFES in Chicago. Check it out for more on improving validation strategies!
Read more: Explore how knowl...Where should training in surgical robotics be going?
Surgery International partners with CMR Surgical for the first-ever Global Robotic Surgery Summit! Join them for this FREE event as they bring together leading experts to discuss the future of #roboticsurgery. Read more here.
Read more: Where should trai...Demystifying the Responsibilities of an EU Authorized Representative
Discover the essential role of the European Authorized Representative (EU AR) for medical devices in Lorit Consultancy comprehensive guide Verena Wieser talks about the pivotal responsibilities, from regulatory compliance to post-market surveillance. Gain insights into how they support non-EU manufacturers navigate the complexities…
Read more: Demystifying the ...Olympus Announces FDA Clearance of RenaFlex™, Its First Single-use Flexible Ureteroscope
Olympus Corporation single-use flexible ureteroscopy system, RenaFlex™, has received clearance from the U.S. Food and Drug Administration (FDA) and will soon be available in the United States. This product assists in the diagnosis and treatment of urological conditions such as #Urolithiasis. Read…
Read more: Olympus Announces...Postpartum depression support for working parents
There are risk factors that increase the likelihood of postpartum depression, as they relate to health, work, family, finances, culture, infrastructure, and social support. HR managers, policymakers, and insurance providers must familiarize themselves with these factors to transform the workplace…
Read more: Postpartum depres...